A novel technique developed by University of Toronto Scarborough researchers can for the first time get a high-resolution profile of which molecules are present inside a living organism. "In a way we've developed this molecular window that can look inside a living system and extract a full ... more
Therapeutic screening for Alzheimer’s disease
Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease.
Research into Alzheimer’s disease has shown that the self-aggregation of the amyloid-β (Aβ) peptide plays a vital role in the development of the disease. A number of techniques have been investigated to study Aβ aggregation, including acoustic wave sensors, electrochemistry and atomic force microscopy.
Now, for the first time, researchers have used an LED-interferometric reflectance imaging sensor (LED-IRIS) to look at the interaction of Aβ peptide with small drug candidates. The sensor uses a Si/SiO2 layered substrate as the sensing surface, which is spotted with Aβ peptide ‘seeds’ using a desktop spotting unit. The sensing surface is incubated with Aβ oligomer solution and drug candidates, which results in differing areas of Aβ peptide aggregation. The sensor monitors this aggregation by detecting optical path length changes. The scientists used green tea polyphenol epigallocatechin-3-gallate and zinc, which are already known to inhibit and promote Aβ peptide aggregation respectively, as model modulators to test the system and show it works.
Kagan Kerman at the University of Toronto at Scarborough, who led the research, said: “We have successfully demonstrated a novel method for high throughput screening of small molecules modulating Aβ growth and it provides a promising platform to facilitate therapeutics discovery for Alzheimer’s disease.”
University of Toronto scientists have discovered a better way to extract proteins from the membranes that encase them, making it easier to study how cells communicate with each other to create human health and disease. Scientists are very interested in understanding how membrane proteins wo ... more
A University of Toronto study on uncertainty in scientific research could shed light on anomalies that arose in early attempts to discover the Higgs boson and even how polls failed to predict the outcome of Donald Trump winning the U.S. presidential election. The study suggests that researc ... more
Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more
Scientists in China have developed a simple microchip that enables quick and inexpensive high-throughput screening of potential drug candidates in 3D cell cultures. Scientists often use cell-based high-throughput screening in the first stage of drug design as a technique to quickly identify ... more
Scientists in Canada have developed a low-cost, portable, paper-based device for detecting antibiotic-resistant bacteria that could be used in the field in remote areas to characterise infectious diseases and assess food and water quality. The scientists used a paper support to hold wax-pat ... more